EVGN
Income statement / Annual
Last year (2025), Evogene Ltd's total revenue was $3.85 M,
a decrease of 54.73% from the previous year.
In 2025, Evogene Ltd's net income was -$8.49 M.
See Evogene Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.85 M |
$8.51 M |
$5.64 M |
$1.68 M |
$930.00 K |
$1.04 M |
$753.00 K |
$1.75 M |
$3.38 M |
$6.54 M |
| Cost of Revenue |
$3.06 M
|
$5.12 M
|
$4.24 M
|
$3.45 M
|
$3.00 M
|
$3.30 M
|
$3.10 M
|
$3.31 M
|
$4.68 M
|
$7.32 M
|
| Gross Profit |
$795.00 K
|
$3.39 M
|
$1.40 M
|
-$1.77 M
|
-$2.07 M
|
-$2.26 M
|
-$2.35 M
|
-$1.56 M
|
-$1.30 M
|
-$778.00 K
|
| Gross Profit Ratio |
0.21
|
0.4
|
0.25
|
-1.06
|
-2.23
|
-2.17
|
-3.12
|
-0.9
|
-0.38
|
-0.12
|
| Research and Development Expenses |
$7.99 M
|
$14.26 M
|
$18.11 M
|
$17.53 M
|
$19.43 M
|
$16.60 M
|
$14.62 M
|
$14.09 M
|
$14.99 M
|
$16.42 M
|
| General & Administrative Expenses |
$0.00
|
$10.04 M
|
$8.67 M
|
$9.40 M
|
$9.34 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$822.00 K
|
$1.01 M
|
$1.02 M
|
$653.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.62 M
|
$10.87 M
|
$9.68 M
|
$10.42 M
|
$9.99 M
|
$7.98 M
|
$5.77 M
|
$5.60 M
|
$5.50 M
|
$3.89 M
|
| Other Expenses |
$2.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$14.79 M
|
$25.12 M
|
$27.79 M
|
$27.94 M
|
$29.42 M
|
$24.57 M
|
$20.39 M
|
$19.69 M
|
$20.49 M
|
$20.31 M
|
| Cost And Expenses |
$17.85 M
|
$30.25 M
|
$32.03 M
|
$31.39 M
|
$32.42 M
|
$27.88 M
|
$23.49 M
|
$23.00 M
|
$25.17 M
|
$27.63 M
|
| Interest Income |
$2.47 M
|
$957.00 K
|
$1.25 M
|
$182.00 K
|
$291.00 K
|
$230.00 K
|
$759.00 K
|
$1.41 M
|
$2.13 M
|
$2.40 M
|
| Interest Expense |
$1.89 M
|
$124.00 K
|
$171.00 K
|
$241.00 K
|
$403.00 K
|
$269.00 K
|
$354.00 K
|
$141.00 K
|
$129.00 K
|
$155.00 K
|
| Depreciation & Amortization |
$1.14 M
|
$2.50 M
|
$2.61 M
|
$2.58 M
|
$2.23 M
|
$2.73 M
|
$2.77 M
|
$2.02 M
|
$2.15 M
|
$2.28 M
|
| EBITDA |
-$12.85 M |
-$15.38 M |
-$23.20 M |
-$26.93 M |
-$27.80 M |
-$23.18 M |
-$15.97 M |
-$18.62 M |
-$18.55 M |
-$17.12 M |
| EBITDA Ratio |
-3.34
|
-1.81
|
-4.11
|
-16.08
|
-29.89
|
-22.29
|
-21.21
|
-10.66
|
-5.49
|
-2.62
|
| Operating Income Ratio |
-3.63
|
-2.55
|
-4.68
|
-17.74
|
-33.86
|
-25.8
|
-30.2
|
-12.17
|
-6.44
|
-3.22
|
| Total Other Income/Expenses Net |
$499.00 K
|
$3.69 M
|
$404.00 K
|
-$39.00 K
|
$1.06 M
|
$661.00 K
|
$3.65 M
|
$472.00 K
|
$958.00 K
|
$1.53 M
|
| Income Before Tax |
-$13.50 M
|
-$18.05 M
|
-$25.99 M
|
-$29.75 M
|
-$30.43 M
|
-$26.17 M
|
-$19.09 M
|
-$20.78 M
|
-$20.83 M
|
-$19.56 M
|
| Income Before Tax Ratio |
-3.5
|
-2.12
|
-4.61
|
-17.76
|
-32.72
|
-25.17
|
-25.35
|
-11.9
|
-6.16
|
-2.99
|
| Income Tax Expense |
-$1.00 K
|
$9.00 K
|
-$33.00 K
|
$90.00 K
|
$13.00 K
|
$32.00 K
|
$24.00 K
|
$30.00 K
|
$11.00 K
|
$36.00 K
|
| Net Income |
-$8.49 M
|
-$16.49 M
|
-$23.88 M
|
-$26.64 M
|
-$27.79 M
|
-$23.37 M
|
-$18.11 M
|
-$20.76 M
|
-$20.84 M
|
-$19.59 M
|
| Net Income Ratio |
-2.2
|
-1.94
|
-4.23
|
-15.9
|
-29.88
|
-22.48
|
-24.05
|
-11.88
|
-6.16
|
-3
|
| EPS |
-1.08 |
-2.89 |
-5.23 |
-6.46 |
-0.68 |
-0.64 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
| EPS Diluted |
-1.08 |
-2.89 |
-5.23 |
-6.46 |
-0.68 |
-0.64 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
| Weighted Average Shares Out |
$7.87 M
|
$5.70 M
|
$4.57 M
|
$4.12 M
|
$41.01 M
|
$36.55 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
| Weighted Average Shares Out Diluted |
$7.87 M
|
$5.70 M
|
$4.57 M
|
$4.12 M
|
$41.01 M
|
$36.55 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
